Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
33.94
-1.46 (-4.12%)
Nov 21, 2024, 4:00 PM EST - Market closed
Ionis Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 5,359 | 7,258 | 5,365 | 4,297 | 7,906 | 8,497 | |
Market Cap Growth | -2.94% | 35.28% | 24.86% | -45.65% | -6.97% | 14.26% | |
Enterprise Value | 5,093 | 6,991 | 4,631 | 3,606 | 6,615 | 7,112 | |
Last Close Price | 35.40 | 50.59 | 37.77 | 30.43 | 56.54 | 60.41 | |
PE Ratio | - | - | - | - | - | 31.80 | |
Forward PE | - | - | - | - | - | 43.66 | |
PS Ratio | 6.43 | 9.22 | 9.13 | 5.30 | 10.84 | 7.57 | |
PB Ratio | 8.43 | 18.77 | 9.37 | 5.57 | 10.64 | 5.04 | |
P/TBV Ratio | 9.53 | 18.77 | 9.37 | 5.57 | 11.05 | 5.88 | |
P/FCF Ratio | - | - | - | 228.03 | 10240.41 | 27.00 | |
P/OCF Ratio | - | - | - | 139.52 | 220.26 | 24.59 | |
PEG Ratio | - | - | - | - | - | 0.89 | |
EV/Sales Ratio | 6.34 | 8.88 | 7.88 | 4.45 | 9.07 | 6.34 | |
EV/EBITDA Ratio | - | - | - | - | - | 18.59 | |
EV/EBIT Ratio | - | - | - | - | - | 19.32 | |
EV/FCF Ratio | - | - | - | 191.38 | 8569.00 | 22.60 | |
Debt / Equity Ratio | 3.01 | 5.09 | 2.39 | 1.62 | 1.26 | 0.47 | |
Debt / EBITDA Ratio | - | - | - | - | - | 2.04 | |
Debt / FCF Ratio | - | - | - | 66.39 | 1217.15 | 2.50 | |
Asset Turnover | 0.27 | 0.29 | 0.23 | 0.32 | 0.26 | 0.38 | |
Inventory Turnover | 33.95 | 35.95 | 36.09 | 27.86 | 27.16 | 34.96 | |
Quick Ratio | 8.24 | 5.43 | 6.49 | 9.13 | 3.30 | 9.42 | |
Current Ratio | 8.91 | 5.90 | 7.07 | 9.75 | 3.56 | 9.97 | |
Return on Equity (ROE) | -73.38% | -76.34% | -40.12% | -3.78% | -39.52% | 20.01% | |
Return on Assets (ROA) | -7.25% | -7.51% | -9.92% | -0.69% | -3.78% | 7.80% | |
Return on Capital (ROIC) | -8.81% | -9.66% | -12.87% | -0.93% | -5.12% | 10.69% | |
Earnings Yield | -6.54% | -5.05% | -5.03% | -0.67% | -5.62% | 3.27% | |
FCF Yield | -6.76% | -4.56% | -5.41% | 0.44% | 0.01% | 3.70% | |
Buyback Yield / Dilution | -2.19% | -0.95% | -0.59% | -1.01% | 8.85% | -14.25% | |
Total Shareholder Return | -2.19% | -0.95% | -0.59% | -1.01% | 8.85% | -14.25% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.